SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors aggressively debate the upcoming announcement of the trial's 80th event, with bullish community members highlighting potential acquisition interest from major pharmaceutical companies while bears express skepticism regarding trial integrity and dilution risks. The conversation is heavily focused on the high short interest and the anticipation that positive topline results could trigger a significant market move.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is generating intense community speculation as investors anticipate imminent Phase 3 VELA data, fueling intense M&A discussions and optimism that sonelokimab will emerge as a best-in-class treatment for hidradenitis suppurativa. The community is closely watching for a potential data release to coincide with upcoming investor presentations, which many believe could trigger a massive rerating event due to the drug's demonstrated efficacy and superior safety profile over existing competition.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending following the announcement of a joint research agreement with Honda, which confirms that another major OEM has validated the company's solid-state battery technology after rigorous testing. The community is actively debating the significance of this partnership, weighing the long-term potential of the technology against frustrations over the lack of immediate commercial-scale revenue.

Roundhill ETF Trust - Roundhill Memory ETF

DRAM is seeing heavy investor interest driven by a perception that the memory sector has shifted from a cyclical trade to a structural AI infrastructure necessity, with strong sentiment tied to supply constraints in High Bandwidth Memory and anticipation for key earnings and IPO catalysts. The community is actively debating the durability of this demand cycle, with many bullish participants viewing recent pullbacks as buying opportunities while others monitor the volatility surrounding sector-wide re-ratings.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is experiencing intense investor interest as the community prepares for a series of pivotal Phase 3 clinical data readouts expected throughout the summer. While discussions are polarized between optimism for potential breakthroughs in mental health treatment and concerns regarding cash burn and dilution, the stock remains a central focus as investors weigh the high-reward upside of these upcoming trials against standard biotech risks.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy Enterprises is trending as investors focus on its role in the AI-driven energy infrastructure sector, with community excitement fueled by the company's recent purchase orders from Frontier Power USA and ongoing developments in zinc-based long-duration energy storage. Bullish sentiment is heavily influenced by the belief that Eos provides a critical solution to power grid bottlenecks required by data centers, leading to active discussions regarding the stock's potential as a multi-year growth opportunity amidst increasing sector-wide demand for reliable, non-flammable energy storage.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is facing heavy volatility as investors debate the impact of AI on its software ecosystem, with community sentiment divided between concerns over profitability and high stock-based compensation versus the belief that institutional interest and upcoming product events will trigger a major reversal. Despite the price pressure, bullish investors are highlighting strong revenue growth and the potential for a short squeeze as key catalysts, while bears remain focused on valuation concerns and the competitive threat posed by emerging generative AI tools.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

Investors are intensely focused on the semiconductor sector as the iShares Semiconductor ETF (SOXX) reaches all-time highs, driven by extreme FOMO and aggressive institutional positioning in AI-related infrastructure. While bulls emphasize strong momentum and the indispensability of chips, many in the community are expressing skepticism, labeling the rally a bubble and warning that overvaluation, high debt, and potential geopolitical instability could lead to a significant reversal.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is trending as market participants closely monitor geopolitical tensions in the Middle East and their potential impact on energy markets and interest rate sentiment. The community is actively debating the durability of the AI-driven tech rally amidst record market highs and ongoing economic uncertainty.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is currently trending due to intense community discussion surrounding its potential integration with space-tech giants and its upcoming June 24th webinar on neutral-atom quantum computing advancements. Investors are closely monitoring the stock's inclusion in the Russell 3000 index, balancing speculative enthusiasm for its quantum-sensing hardware and government contracts against concerns over market volatility and sector rotation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Zacks Analyst Blog Highlights UnitedHealth, Donaldson, Lowe's and ePlus 

Recent dividend hikes from UNH, DCI, LOW, PLUS and TD are drawing attention as investors seek stability amid inflation and geopolitical uncertainty.

Donaldson's Q3 Earnings & Revenues Top Estimates, Increase Y/Y

DCI beats Q3 earnings and revenue estimates as Mobile Solutions and Life Sciences growth lifted sales, while fiscal 2026 guidance remained intact.

5 Stocks to Watch on Their Recent Dividend Hikes in a Volatile Market

UNH, DCI, LOW, PLUS and TD stand out for cautious investors as markets weigh inflation, growth and geopolitics amid recent dividend hikes.

 Company News for Jun 3, 2026

Companies in The News Are: DG,SIG,DCI,STM

DCI Q3 Earnings Call Highlights Margin Recovery, Facet Deal

Donaldson says Q3 execution and not demand was the issue, as it posts record sales and EPS, narrows its 2026 guidance, and closes Facet.

Donaldson Shrugs Off Global Uncertainty, Posts Record Sales Near $1 Billion

Donaldson (NYSE: DCI) beats Q3 2026 estimates with $995.1M revenue and $1.06 EPS. Stock rises 2.3% on strong Mobile & Life Sciences.read more...

Donaldson Rewards Shareholders With 6.7% Dividend Increase

DCI raises its dividend again, extending a decades-long streak of shareholder returns backed by strong cash flow.

Donaldson (DCI) Q3 2026 Earnings Transcript

Donaldson (DCI) Q3 2026 Earnings Transcript...

Donaldson (DCI) Reports Q3 Earnings: What Key Metrics Have to Say

The headline numbers for Donaldson (DCI) give insight into how the company performed in the quarter ended April 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Donaldson (DCI) Q3 Earnings and Revenues Beat Estimates

Donaldson (DCI) delivered earnings and revenue surprises of +0.57% and +1.64%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?

Donaldson Co., Inc. engages in the manufacture of filtration systems and replacement parts. It operates through the following segments: Mobile Solutions, Industrial Solutions, and Life Sciences. The Mobile Solutions segment is involved deals with replacement filters for both air and liquid filtration applications and filtration housings for new equipment production and systems related to exhaust and emissions. The Industrial Solutions segment focuses on industrial air filtration, industrial gases, industrial hydraulics, power generation and aerospace, and defense business units. The Life Sciences segment consists of bioprocessing, food and beverage, medical device, vehicle electrification, microelectronics and disk drive business units. The company was founded by Frank Donaldson Sr. in 1915 and is headquartered in Minneapolis, MN.

Donaldson Co. Inc.

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$85.52
Prev Close	$85.35
Open	$86.20
Dividend Yield	1.58%
50-Day Moving Average	$85.78
Beta	0.87
Avg. Volume	561,277.07
PE Ratio	22.99

52-Week High	$112.84
52-Week Low	$67.71
Market Capitalization	$9.91B
EPS (Annual)	$3.05
Price to Book	5.85
Revenue Per Employee	$246,060.00

DCIDonaldson Co. Inc.

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest DCI News